Utilization of Hepatitis C Positive Kidneys in Negative Recipients

NCT03801707 PHASE2, PHASE3 COMPLETED Results posted

To evaluate the safety and feasibility of transplanting kidneys from Hepatitis C virus (HCV) infected donors into recipients without HCV infection

Details

Lead sponsor	Ohio State University
Phase	PHASE2, PHASE3
Status	COMPLETED
Enrolment	54
Start date	Fri Mar 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Apr 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Kidney Transplant
• Hepatitis C
• HCV

Interventions

• Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]
• Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet [MAVYRET]

Countries

United States